Product Code: TMRGL47580
Gastrointestinal Bleeding Treatment Market - Scope of Report
TMR's report on the global gastrointestinal bleeding treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global gastrointestinal bleeding treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global gastrointestinal bleeding treatment market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the gastrointestinal bleeding treatment market.
Market Snapshot |
Market Value in 2022 | US$ 518.3 Mn |
Market Value in 2031 | US$ 824.9 Mn |
CAGR | 5.4% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global gastrointestinal bleeding treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global gastrointestinal bleeding treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global gastrointestinal bleeding treatment market.
The report delves into the competitive landscape of the global gastrointestinal bleeding treatment market. Key players operating in the global gastrointestinal bleeding treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global gastrointestinal bleeding treatment market profiled in this report.
Key Questions Answered in Global gastrointestinal bleeding treatment Market Report:
- What is the sales/revenue generated by gastrointestinal bleeding treatment across all regions during the forecast period?
- What are the opportunities in the global gastrointestinal bleeding treatment market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Gastrointestinal Bleeding Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global gastrointestinal bleeding treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global gastrointestinal bleeding treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global gastrointestinal bleeding treatment market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Gastrointestinal Bleeding Treatment Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product/Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Endoscopic Hemostatic Devices
- 6.3.1.1. Thermal Devices
- 6.3.1.2. Mechanical Devices
- 6.3.2. Closure Devices
- 6.3.3. Others
- 6.4. Market Attractiveness Analysis, by Product
7. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by GI Tract Division
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by GI Tract Division, 2017-2031
- 7.3.1. Upper GI Tract
- 7.3.2. Lower GI Tract
- 7.4. Market Attractiveness Analysis, by GI Tract Division
8. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Clinics
- 8.3.3. Ambulatory Surgical Centers
- 8.3.4. Others
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region, 2017-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Gastrointestinal Bleeding Treatment Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Key Findings
- 10.3. Market Value Forecast, by Product, 2017-2031
- 10.3.1. Endoscopic Hemostatic Devices
- 10.3.1.1. Thermal Devices
- 10.3.1.2. Mechanical Devices
- 10.3.2. Closure Devices
- 10.3.3. Others
- 10.4. Market Value Forecast, by GI Tract Division, 2017-2031
- 10.4.1. Upper GI Tract
- 10.4.2. Lower GI Tract
- 10.5. Market Value Forecast, by End-user, 2017-2031
- 10.5.1. Hospitals
- 10.5.2. Clinics
- 10.5.3. Ambulatory Surgical Centers
- 10.5.4. Others
- 10.6. Market Value Forecast, by Country, 2017-2031
- 10.6.1. U.S.
- 10.6.2. Canada
- 10.7. Market Attractiveness Analysis
- 10.7.1. By Product
- 10.7.2. By GI Tract Division
- 10.7.3. By End-user
- 10.7.4. By Country
11. Europe Gastrointestinal Bleeding Treatment Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Key Findings
- 11.3. Market Value Forecast, by Product, 2017-2031
- 11.3.1. Endoscopic Hemostatic Devices
- 11.3.1.1. Thermal Devices
- 11.3.1.2. Mechanical Devices
- 11.3.2. Closure Devices
- 11.3.3. Others
- 11.4. Market Value Forecast, by GI Tract Division, 2017-2031
- 11.4.1. Upper GI Tract
- 11.4.2. Lower GI Tract
- 11.5. Market Value Forecast, by End-user, 2017-2031
- 11.5.1. Hospitals
- 11.5.2. Clinics
- 11.5.3. Ambulatory Surgical Centers
- 11.5.4. Others
- 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.6.1. Germany
- 11.6.2. U.K.
- 11.6.3. France
- 11.6.4. Italy
- 11.6.5. Spain
- 11.6.6. Rest of Europe
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By GI Tract Division
- 11.7.3. By End-user
- 11.7.4. By Country/Sub-region
12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Key Findings
- 12.3. Market Value Forecast, by Product, 2017-2031
- 12.3.1. Endoscopic Hemostatic Devices
- 12.3.1.1. Thermal Devices
- 12.3.1.2. Mechanical Devices
- 12.3.2. Closure Devices
- 12.3.3. Others
- 12.4. Market Value Forecast, by GI Tract Division, 2017-2031
- 12.4.1. Upper GI Tract
- 12.4.2. Lower GI Tract
- 12.5. Market Value Forecast, by End-user, 2017-2031
- 12.5.1. Hospitals
- 12.5.2. Clinics
- 12.5.3. Ambulatory Surgical Centers
- 12.5.4. Others
- 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. China
- 12.6.2. Japan
- 12.6.3. India
- 12.6.4. Australia & New Zealand
- 12.6.5. Rest of Asia Pacific
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Product
- 12.7.2. By GI Tract Division
- 12.7.3. By End-user
- 12.7.4. By Country/Sub-region
13. Latin America Gastrointestinal Bleeding Treatment Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Key Findings
- 13.3. Market Value Forecast, by Product, 2017-2031
- 13.3.1. Endoscopic Hemostatic Devices
- 13.3.1.1. Thermal Devices
- 13.3.1.2. Mechanical Devices
- 13.3.2. Closure Devices
- 13.3.3. Others
- 13.4. Market Value Forecast, by GI Tract Division, 2017-2031
- 13.4.1. Upper GI Tract
- 13.4.2. Lower GI Tract
- 13.5. Market Value Forecast, by End-user, 2017-2031
- 13.5.1. Hospitals
- 13.5.2. Clinics
- 13.5.3. Ambulatory Surgical Centers
- 13.5.4. Others
- 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. Brazil
- 13.6.2. Mexico
- 13.6.3. Rest of Latin America
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Product
- 13.7.2. By GI Tract Division
- 13.7.3. By End-user
- 13.7.4. By Country/Sub-region
14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Key Findings
- 14.3. Market Value Forecast, by Product, 2017-2031
- 14.3.1. Endoscopic Hemostatic Devices
- 14.3.1.1. Thermal Devices
- 14.3.1.2. Mechanical Devices
- 14.3.2. Closure Devices
- 14.3.3. Others
- 14.4. Market Value Forecast, by GI Tract Division, 2017-2031
- 14.4.1. Upper GI Tract
- 14.4.2. Lower GI Tract
- 14.5. Market Value Forecast, by End-user, 2017-2031
- 14.5.1. Hospitals
- 14.5.2. Clinics
- 14.5.3. Ambulatory Surgical Centers
- 14.5.4. Others
- 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. GCC Countries
- 14.6.2. South Africa
- 14.6.3. Rest of Middle East & Africa
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Product
- 14.7.2. By GI Tract Division
- 14.7.3. By End-user
- 14.7.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
- 15.2. Market Share Analysis, by Company (2022)
- 15.3. Company Profiles
- 15.3.1. Boston Scientific Corporation
- 15.3.1.1. Company Overview
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Financial Overview
- 15.3.1.5. Strategic Overview
- 15.3.2. Olympus Corporation
- 15.3.2.1. Company Overview
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Financial Overview
- 15.3.2.5. Strategic Overview
- 15.3.3. CONMED Corporation
- 15.3.3.1. Company Overview
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Financial Overview
- 15.3.3.5. Strategic Overview
- 15.3.4. Cook Group
- 15.3.4.1. Company Overview
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Financial Overview
- 15.3.4.5. Strategic Overview
- 15.3.5. Ovesco Endoscopy AG
- 15.3.5.1. Company Overview
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Financial Overview
- 15.3.5.5. Strategic Overview
- 15.3.6. Erbe Elektromedizin GmbH
- 15.3.6.1. Company Overview
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Financial Overview
- 15.3.6.5. Strategic Overview
- 15.3.7. STERIS
- 15.3.7.1. Company Overview
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Financial Overview
- 15.3.7.5. Strategic Overview
- 15.3.8. US Medical Innovations
- 15.3.8.1. Company Overview
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Financial Overview
- 15.3.8.5. Strategic Overview